Association of CORADS classification and cardiorespiratory fitness profile among symptomatic and asymptomatic post-coronavirus disease 2019 individuals
{"title":"Association of CORADS classification and cardiorespiratory fitness profile among symptomatic and asymptomatic post-coronavirus disease 2019 individuals","authors":"MAnbu Priya, S Hariharan, K Gayathri, JR Abishek","doi":"10.4103/ajprhc.ajprhc_35_23","DOIUrl":null,"url":null,"abstract":"Background: Physiotherapy treatment is focused for coronavirus disease 2019 (COVID-19) patients in critical, acute, and postacute phases, and the physiotherapists have the responsibility of recovering COVID-19 individuals back to their usual quality of life (QOL). Hence, evaluating the COVID-19 survivor’s QOL is important to improve their independence. Objective: This study aims to assess the patient’s cardiorespiratory fitness in association with their CORADS classification and QOL in post-COVID-19 individuals is essential during this pandemic. Methodology: A retrospective study was conducted with 60 post-COVID-19 individuals who were recruited by convenience. Result: P value of symptomatic and asymptomatic is 0.001, which is considered significant based on their VO2, and that the mean difference, standard error difference, and 95% confidence interval of the difference for both are −6.68, 0.73, and −8.14, respectively. The physical component of QOL is significant in symptomatic individuals (0.005), but all other components are nonsignificant. Conclusion: The impact of COVID-19 on health-related QOL and cardiorespiratory fitness is higher in symptomatic individuals than symptomatic individuals.","PeriodicalId":8534,"journal":{"name":"Asian Journal of Pharmaceutical Research and Health Care","volume":"99 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutical Research and Health Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ajprhc.ajprhc_35_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Physiotherapy treatment is focused for coronavirus disease 2019 (COVID-19) patients in critical, acute, and postacute phases, and the physiotherapists have the responsibility of recovering COVID-19 individuals back to their usual quality of life (QOL). Hence, evaluating the COVID-19 survivor’s QOL is important to improve their independence. Objective: This study aims to assess the patient’s cardiorespiratory fitness in association with their CORADS classification and QOL in post-COVID-19 individuals is essential during this pandemic. Methodology: A retrospective study was conducted with 60 post-COVID-19 individuals who were recruited by convenience. Result: P value of symptomatic and asymptomatic is 0.001, which is considered significant based on their VO2, and that the mean difference, standard error difference, and 95% confidence interval of the difference for both are −6.68, 0.73, and −8.14, respectively. The physical component of QOL is significant in symptomatic individuals (0.005), but all other components are nonsignificant. Conclusion: The impact of COVID-19 on health-related QOL and cardiorespiratory fitness is higher in symptomatic individuals than symptomatic individuals.